Takeda Pharmaceutical (TAK) Shares Outstanding (2017 - 2026)
Takeda Pharmaceutical (TAK) Shares Outstanding (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 43.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | 31.59 Bn |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 497.70 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 1.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.58 Bn |
| Dec 31, 2025 | 1.57 Bn |
| Sep 30, 2025 | 1.57 Bn |
| Jun 30, 2025 | 1.58 Bn |
| Mar 31, 2025 | 1.58 Bn |
| Dec 31, 2024 | 1.58 Bn |
| Sep 30, 2024 | 1.58 Bn |
| Jun 30, 2024 | 1.56 Bn |
| Mar 31, 2024 | 1.56 Bn |
| Dec 31, 2023 | 15.58 Bn |
| Sep 30, 2023 | 12.71 Bn |
| Jun 30, 2023 | 10.62 Bn |
| Mar 31, 2023 | 1.55 Bn |
| Dec 31, 2022 | 14.24 Bn |
| Sep 30, 2022 | 11.33 Bn |
| Jun 30, 2022 | 8.65 Bn |
| Mar 31, 2022 | 1.56 Bn |
| Dec 31, 2021 | 10.89 Bn |
| Sep 30, 2021 | 9.30 Bn |
| Jun 30, 2021 | 9.18 Bn |